Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
July 27, 2022 08:45 ET
|
Biofrontera Inc.
WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today it has...